
Big Pharma’s Patent Abuses Are Fueling the Drug Pricing Crisis
The latest in news from I-MAK experts.
For press inquiries, please contact simon@i-mak.org.
Top 5 Global Health Headlines: India Rejects HIV Patent
India has rejected a patent application for Abbott’s HIV/AIDS treatment Kaletra, reigniting a debate over the country’s patent rules.
Indian Government Rejects Abbott’s Patent Application For Second-Line ARV
HIV Drug to Be Distributed Worldwide
Patent On AIDS Medicine Denied In India; Seen Unlocking Market
India rejects US firms patent for anti-HIV drugs
Indian Patent Office Rejects Abbott’s Kaletra Patent
Patent Denied On AIDS Drug In India
Patent office rejects Abbott’s application on HIV drug
India rejects Abbott patent on Kaletra
Learn more about how you can help build a more equitable system for all